HCP Plastene Bulkpack Intrinsic Value
HCP Plastene Bulkpack (HPBL) median intrinsic value is ₹224.16 from 8 valuation models (range ₹72–₹366), vs current price ₹182.85 — +22.6% upside (Trading Below Calculated Value), margin of safety 18.4%. For current market price and key ratios, visit HPBL share price.
HPBL Valuation Methods Summary — DCF, Graham Number & P/E
HCP Plastene Bulkpack intrinsic value across 8 models vs current price ₹182.85 — upside/downside and value range per method. Browse HPBL financial statements for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹224.16 | ₹179.33 - ₹268.99 | +22.6% | EPS: ₹18.68, Sector P/E: 12x |
| Book Value Method | asset | ₹71.82 | ₹64.64 - ₹79.00 | -60.7% | Book Value/Share: ₹71.82, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹365.70 | ₹329.13 - ₹402.27 | +100.0% | Revenue/Share: ₹727.27, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹283.64 | ₹255.28 - ₹312.00 | +55.1% | EBITDA: ₹52.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹119.55 | ₹107.59 - ₹131.50 | -34.6% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹153.92 | ₹138.53 - ₹169.31 | -15.8% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹290.91 | ₹261.82 - ₹320.00 | +59.1% | ROE: 25.3%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹143.64 | ₹129.28 - ₹158.00 | -21.4% | EPS: ₹18.68, BVPS: ₹71.82 |
HPBL Intrinsic Value vs Market Price — All Valuation Models
HCP Plastene Bulkpack fair value range ₹72–₹366 vs current market price ₹182.85 across 8 valuation models. Compare with HPBL fundamental valuation to assess whether the stock is under or overvalued.
HPBL Intrinsic Value Analysis — Undervalued or Overvalued?
HCP Plastene Bulkpack median intrinsic value ₹224.16, current price ₹182.85 — Trading Below Calculated Value by 22.6%, margin of safety 18.4%.
What is the intrinsic value of HPBL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of HCP Plastene Bulkpack (HPBL) is ₹224.16 (median value). With the current market price of ₹182.85, this represents a +22.6% variance from our estimated fair value.
The valuation range spans from ₹71.82 to ₹365.70, indicating ₹71.82 - ₹365.70.
Is HPBL undervalued or overvalued?
Based on our multi-method analysis, HCP Plastene Bulkpack (HPBL) appears to be trading below calculated value by approximately 22.6%.
HPBL Financial Health — Key Ratios vs Industry Benchmarks
HCP Plastene Bulkpack financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 25.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.81x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
HPBL Cash Flow Quality — Operating & Free Cash Flow
HCP Plastene Bulkpack operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-19 Cr | ₹-19 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-19 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-20 Cr | ₹-27 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-23 Cr | ₹-52 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-16 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |